Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial [corrected] [published erratum appears in CLIN THER 2009 Apr;31(4):920].

Autor: Nelson HS (AUTHOR), Gross NJ (AUTHOR), Levine B (AUTHOR), Kerwin EM (AUTHOR), Rinehart M (AUTHOR), Denis-Mize K (AUTHOR), Formoterol Study Group (CORPORATE AUTHOR)
Zdroj: Clinical Therapeutics. Oct2007, Vol. 29 Issue 10, p2167-2178. 12p.
Databáze: Academic Search Ultimate
Externí odkaz: